Skip to search formSkip to main contentSkip to account menu

TX-001HR

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

EstradiolProgesterone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and…
Abstract Objective: In the REPLENISH trial, women receiving TX-001HR—an oral, softgel capsule, combining 17β-estradiol (E2) and… 
2019
2019
Effects of TX-001HR in Women With Menopause [19J]
Research Support includes receipt of drugs, supplies, equipment or other inkind support; Lilly: Other Research Support includes… 
2017
2017
REPLENISH Trial: Combination Capsule of Estradiol/Progesterone (TX-001HR) for Treating Hot Flushes [5M]
2017
2017
REPLENISH trial: TX-001HR (17β-estradiol and progesterone combination) significantly improved moderate to severe hot flushes in postmenopausal women
Review
2015
Review
2015
17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review.
2015
2015
A new solubilized vaginal estradiol in a VagiCap™ for the treatment of vaginal atrophy
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)